CAS 603139-19-1: Odanacatib
Formula:C25H27F4N3O3S
InChI:InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1
InChI key:InChIKey=FWIVDMJALNEADT-SFTDATJTSA-N
SMILES:N#CC1(NC(=O)C(NC(C2=CC=C(C=C2)C=3C=CC(=CC3)S(=O)(=O)C)C(F)(F)F)CC(F)(C)C)CC1
- Synonyms:
- (2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide
- N<sup>1</sup>-[(1-Cyanocyclopropyl)-4-fluoro-N<sup>2</sup>-[(1S)-2,2,2-trifluoro-1-[4-methylsulfonyl]-1,1′-biphenyl-4-yl] ethyl]-<span class="text-smallcaps">L</span>-leucinamide
- Odanacatib
- MK 0822
- N1-[(1-Cyanocyclopropyl)-4-fluoro-N2-[(1S)-2,2,2-trifluoro-1-[4-methylsulfonyl]-1,1′-biphenyl-4-yl] ethyl]-L-leucinamide
- Pentanamide, N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4′-(methylsulfonyl)[1,1′-biphenyl]-4-yl]ethyl]amino]-, (2S)-
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Odanacatib REF: IN-DA0039T3CAS: 603139-19-1 | 98% | To inquire | Mon 17 Mar 25 |
![]() | Odanacatib REF: TM-T6035CAS: 603139-19-1 | 98.53% - 99.92% | 49.00 €~607.00 € | Mon 24 Mar 25 |
![]() | MK-0822 REF: TR-M425015CAS: 603139-19-1 | - - - | 251.00 €~1,355.00 € | Thu 27 Mar 25 |
![]() | MK 0822 REF: 3D-FM65088CAS: 603139-19-1 | Min. 95% | 292.00 €~815.00 € | Fri 28 Mar 25 |

Odanacatib
Ref: IN-DA0039T3
1mg | 76.00 € | ||
2mg | 104.00 € | ||
5mg | 154.00 € | ||
10mg | 165.00 € | ||
25mg | 306.00 € | ||
50mg | 556.00 € | ||
100mg | To inquire |

Odanacatib
Ref: TM-T6035
1mg | 49.00 € | ||
2mg | 70.00 € | ||
5mg | 105.00 € | ||
10mg | 168.00 € | ||
25mg | 273.00 € | ||
50mg | 410.00 € | ||
100mg | 607.00 € | ||
1mL*10mM (DMSO) | 118.00 € |

MK-0822
Controlled ProductRef: TR-M425015
10mg | 251.00 € | ||
50mg | 834.00 € | ||
100mg | 1,355.00 € |

MK 0822
Ref: 3D-FM65088
10mg | 292.00 € | ||
50mg | 815.00 € |